PDCD1 and neoplasm: Jenkins et al. demonstrated cytokine response to PD-1 and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibition in patient-derived organotypic tumor spheroids that maintained TME components, such as tumor stroma and immune cells [13].